• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Sex-Matched Transfusions May Reduce Mortality

October 6, 2022

While plasma from female donors increases the risk of transfusion-related acute lung injury (TRALI), observational studies have had conflicting results on the effect of donor sex on RBC transfusion recipient outcome.  In order to better understand the effect of donor sex on transfusion recipient mortality, researchers in Denmark evaluated data from the Danish Capital Region Blood Bank Transfusion Database to emulate several hypothetical randomized trials.  Data from 90,917 adult patients with no history of transfusions in the past 12 months (54.6% female) who were transfused with leukoreduced RBCs from either males or females only between 2008 and 2018 were eligible.  Since Danish blood banks follow a first-in-first out policy for RBC units, the transfusion of RBC units was random according to donor sex.  Patients were only included once—i.e. only the first transfusion event was included in the data analysis.  Targeted maximum likelihood estimation method was used in conjunction with ensemble machine learning to mimic sex-stratified trials to compare the effectiveness of transfusing RBCs from either only male or female donors.  Overall, 14.9% of male and 11.2% of female transfusion recipients died during the 28-day follow-up.  The 28-day survival for male recipients was 2.06 percentage points (95% C.I., 1.81 to 2.32, P<0.0001) higher with transfusion from all male donors compared with all female donors.  Compared to the current first-in-first-out practice, the 28-day survival for female recipients was 0.64 percentage points higher from all male donors and 0.62 percentage points higher from all female donors.  Further research and randomized clinical trials are needed to confirm and explain the mechanism behind the morbidity and mortality associated with blood donor sex.

Reference:

1. Bruun-Rasmussen P, Andersen PK, Banasik K, Brunak S, and PI Johansson.  Estimating the effect of donor sex on red blood cell transfused patient mortality:  a retrospective cohort study using a targeted learning and emulated trials-based approach.  EClinicalMedicine 2022; 51

Filed Under

  • News
  • RBC Transfusion

Recommended

  • RBC Transfusions Are Best for Anemic Patients with Breast Cancer

  • Alloimmunization to One RBC Antigen Triggers Alloimmunization to Other RBC Antigens

  • Leukoreduction of Platelet Units Followed by Mirasol Pathogen Reduction May Prevent Alloimmunization

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Directed Blood Donations Should be Limited

  • Babesia Infection Reduces Red Cell Deformability

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley